Revolutionizing Healthcare At Gsk
Life At Gsk Gsk Au GSK cuts 2024 vaccine sales forecast for second time this year Strong specialty medicines offset lower vaccine sales - CEO Q3 EPS beats market expectations Shares down 39% at 0958 GMT Oct 30 Settlement resolves 80,000 or 93% of pending US cases GSK top gainer on FTSE-100, best one-day gain since Dec 2022 To record 18 billion pounds charge in Q3 results Oct 10 (Reuters) - GSK (GSKL
Life At Gsk Gsk India
Life At Gsk Gsk
Media Gsk
Engineering At Gsk Gsk
Life At Gsk Gsk India
Comments are closed.